Randstad NV (0NW2)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 41.05 |
|---|---|
| 52-week range | 21.31 – 41.66 |
| Return, 1 month / 3 months | +13.2% / +13.4% |
| Return, 1 year / 3 years | +27.4% / +3.2% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 39.7% |
| Worst drawdown (1 year) | -33.6% |
| Average daily value traded | 5.57M EUR |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Randstad is a human resources services company based in the Netherlands. It supplies temporary and permanent staff to businesses and also offers professional recruitment, payroll administration and other workforce services. Its clients range from small firms to large organisations in office, industrial, technical and professional sectors, and it operates through a family of recruitment brands across Europe, North America and other parts of the world. Randstad helps employers find workers and helps people find jobs.
The shares are listed on the London Exchange in UK under the code 0NW2, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Randstad NV (0NW2) trades on the London Exchange in UK. It last closed at EUR 41.05 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 579 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.4% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 38.3% | ||
| From 52-week high | -1.5% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.4% | ||
| 6-month return | 56.9% | ||
| 12-month return, skipping the last month | 12.5% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.6% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.57M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +18.5% |
|---|---|
| 1 month | +13.2% |
| 3 months | +13.4% |
| 6 months | +56.9% |
| 1 year | +27.4% |
| 3 years | +3.2% |
| 5 years | −8.8% |
Signals
| 50-day / 200-day average | 37.26 / 29.68 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Mar 2026 | EUR 1.6200 |
| 28 Mar 2025 | EUR 1.6200 |
| 26 Sep 2024 | EUR 1.2700 |
| 28 Mar 2024 | EUR 2.2800 |
| 30 Mar 2023 | EUR 2.8500 |
| 29 Sep 2022 | EUR 2.8100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.